503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-9.63%
Revenue decline while CRWD shows 5.94% growth. Joel Greenblatt would examine competitive position erosion.
-39.80%
Cost reduction while CRWD shows 7.31% growth. Joel Greenblatt would examine competitive advantage.
-0.58%
Gross profit decline while CRWD shows 5.45% growth. Joel Greenblatt would examine competitive position.
10.02%
Margin expansion while CRWD shows decline. John Neff would investigate competitive advantages.
-48.23%
R&D reduction while CRWD shows 3.75% growth. Joel Greenblatt would examine competitive risk.
237.05%
G&A growth above 1.5x CRWD's 7.72%. Michael Burry would check for operational inefficiency.
-21.85%
Marketing expense reduction while CRWD shows 1.68% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
2.40%
Operating expenses growth 50-75% of CRWD's 3.48%. Bruce Berkowitz would examine efficiency.
-9.00%
Total costs reduction while CRWD shows 4.38% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
-17.00%
Both companies reducing D&A. Martin Whitman would check industry patterns.
-13.36%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
-38.92%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-13.36%
Operating income decline while CRWD shows 9.37% growth. Joel Greenblatt would examine position.
-4.12%
Operating margin decline while CRWD shows 14.45% growth. Joel Greenblatt would examine position.
19.59%
Similar other expenses growth to CRWD's 18.80%. Walter Schloss would investigate industry patterns.
-1.43%
Pre-tax income decline while CRWD shows 20.26% growth. Joel Greenblatt would examine position.
9.08%
Pre-tax margin growth below 50% of CRWD's 24.73%. Michael Burry would check for structural issues.
26.34%
Tax expense growth while CRWD reduces burden. John Neff would investigate differences.
-15.11%
Net income decline while CRWD shows 29.52% growth. Joel Greenblatt would examine position.
-6.06%
Net margin decline while CRWD shows 33.47% growth. Joel Greenblatt would examine position.
-14.29%
EPS decline while CRWD shows 29.55% growth. Joel Greenblatt would examine position.
-14.29%
Diluted EPS decline while CRWD shows 29.55% growth. Joel Greenblatt would examine position.
-0.23%
Share count reduction while CRWD shows 0.59% change. Joel Greenblatt would examine strategy.
-0.39%
Diluted share reduction while CRWD shows 0.59% change. Joel Greenblatt would examine strategy.